Clinical effects of neoadjuvant chemotherapy on early-stage bulky cervical carcinoma

Mingfei GUAN,He HUANG,Jihong LIU

DOI: https://doi.org/10.3969/j.issn.1672-1861.2008.03.003

2008-01-01

Abstract:Objective To evaluate the effects and the related factors of neoadjuvant chemotherapy(NACT)followed by radical surgery on early-stage bulky cervical carcinoma.Methods A total of 140 cases with bulky IB-IIA cervical carcinoma were retrospectively reviewed and divided into two groups according to pre-operative chemotherapy:69 cases in the NACT group who accepted 1~3 courses of chemotherapy before surgery;71 cases in the control group who underwent radical surgery directly.The blood loss during operation,pathological characteristics and surgical complications were compared between two groups.Results The total response rate for NACT was 87.0%.Compared to the control group,the rate of lymphatic vascular space invasion(LVSI)was lower in NACT group(14.08% vs 4.35%,P<0.05).However,the blood loss during operation was more and the rate of blood transfusion was higher in the NACT group(15.49% vs 46.38%,P<0.05).The rates of deep stromal invasion,lymph node metastasis,parametrial involvement,post-operative radiotherapy were 53.62%,26.09%,2.90%,63.77% in NACT group,respectively,and 67.61%,29.58%,1.41%,74.65% in the control group,respectively,without significant difference between two groups(all P>0.05).No difference was found between the two groups in surgical complications and operating time(both P>0.05).The response rates for NACT with 2~3 courses were better than with 1 course(89.2% vs 68.1%,P<0.05).The response rate to NACT were higher in the patients with squamous cell carcinoma antigen(SCC-Ag)3.0 ng/ml in sera than those with SCC-Ag 3.0 ng/ml(100% vs 82.5%,P<0.05).The other possible factors,including hemoglobin level,clinical stage,size of tumor,macroscopic types,histology types and grades,were not associated with the response rates of chemotherapy.Conclusions Neoadjuvant chemotherapy is effective as a pre-operative therapy for early-stage bulky cervical carcinoma with a higher response rate.It may reduce the rate of LVSI.The pre-treat ment level of SCC-Ag may predict the efficacy of NACT.